Company / Total Assets
GYRE THERAPEUTICS, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$166.1M
FY2025
5-year range
$55.7M / $166.1M
FY2021-FY2025
Trend
+32.5%
vs FY2024
Sector context
#201 of 214
Health Care
What the data says
Among 214 Health Care companies, GYRE THERAPEUTICS, INC. is in the bottom 6% for total assets. Total Assets has increased for 4 consecutive years, from $56M in FY2021 to $166M in FY2025.
Based on SEC 10-K filings.
$166M in FY2025 with a 5-year CAGR of +11.9%.
Improved from $117M to $166M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +25.2%
- 5-Year CAGR
- +11.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 214This company $166.1M Sector average $7.5B
▼
-97.8% below sector average
Key checks
Key Insights
- GYRE THERAPEUTICS, INC.'s total assets has grown for 4 consecutive years.
- 5-year CAGR of +11.9%, indicating consistent growth.
- In FY2025, total assets increased 32.5% year-over-year.
- Ranks #201 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $166.1M | +32.5% |
| FY2024 | $125.4M | +7.6% |
| FY2023 | $116.5M | +37.5% |
| FY2022 | $84.8M | +52.3% |
| FY2021 | $55.7M | -41.3% |
| FY2020 | $94.8M | -3.8% |
| FY2019 | $98.6M | -21.1% |
| FY2018 | $124.9M | +216.1% |
| FY2017 | $39.5M | +3.7% |
| FY2016 | $38.1M | -45.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026